These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. [Hypersensitivity to allopurinol. Efficacy of a desensitizing protocol in 3 cases]. Domínguez Ortega J; Trindade C; Alonso Llamazares A; Castellano Bravo A; Cimarra Alvárez-Lovel M; Martínez-Cócera C An Med Interna; 2001 Jan; 18(1):27-8. PubMed ID: 11387841 [TBL] [Abstract][Full Text] [Related]
30. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. Gutiérrez-Macías A; Lizarralde-Palacios E; Martínez-Odriozola P; Miguel-De la Villa F BMJ; 2005 Sep; 331(7517):623-4. PubMed ID: 16166134 [No Abstract] [Full Text] [Related]
31. [Hypersensitivity reaction to allopurinol]. Malè PJ; Schaer B; Posternak F Schweiz Med Wochenschr; 1978 May; 108(18):681-3. PubMed ID: 653331 [TBL] [Abstract][Full Text] [Related]
32. [Syndrome of allopurinol hypersensitivity. Report of a new case and review of the Spanish literature]. Berbegal J; Morera J; Andrada E; Navarro V; Lluch V; López-Benito I Med Clin (Barc); 1994 Feb; 102(5):178-80. PubMed ID: 8127168 [TBL] [Abstract][Full Text] [Related]
33. [Allopurinol hypersensitivity syndrome: Liver transplantation after treatment of asymptomatic hyperuricaemia]. Miederer SE; Miederer KO Dtsch Med Wochenschr; 2014 Dec; 139(49):2537-40. PubMed ID: 25423467 [TBL] [Abstract][Full Text] [Related]
34. [A case of vanishing bile duct syndrome associated with hypersensitivity to allopurinol]. Choi SH; Yang SH; Song YB; Kim HJ; Seo YT; Choi DS; Moon KH; Byun JH; Yu ES Korean J Hepatol; 2005 Mar; 11(1):80-5. PubMed ID: 15788888 [TBL] [Abstract][Full Text] [Related]
35. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Stamp LK; Taylor WJ; Jones PB; Dockerty JL; Drake J; Frampton C; Dalbeth N Arthritis Rheum; 2012 Aug; 64(8):2529-36. PubMed ID: 22488501 [TBL] [Abstract][Full Text] [Related]
36. [Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment]. Urban T; Maquarre E; Housset C; Chouaid C; Devin E; Lebeau B Rev Mal Respir; 1995; 12(3):314-6. PubMed ID: 7638430 [TBL] [Abstract][Full Text] [Related]
37. Allopurinol hypersensitivity syndrome with acute generalized exanthematous pustulosis manifestations. Teo WL; Pang SM; Koh HY Cutan Ocul Toxicol; 2011 Sep; 30(3):243-4. PubMed ID: 21345152 [TBL] [Abstract][Full Text] [Related]
38. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Stamp LK; Day RO; Yun J Nat Rev Rheumatol; 2016 Apr; 12(4):235-42. PubMed ID: 26416594 [TBL] [Abstract][Full Text] [Related]
39. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. Min HK; Lee B; Kwok SK; Ju JH; Kim WU; Park YM; Park SH Korean J Intern Med; 2015 Jul; 30(4):521-30. PubMed ID: 26161019 [TBL] [Abstract][Full Text] [Related]
40. A review of inpatients with adverse drug reactions to allopurinol. Khoo BP; Leow YH Singapore Med J; 2000 Apr; 41(4):156-60. PubMed ID: 11063179 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]